Safety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral Dose
Clinical trial NCT06092788 · COMPLETED
Trial details
- NCT number
- NCT06092788
- Sponsor
- ATXA Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-24
- Primary completion
- 2024-01-17
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.